Unlike some peptides where more is simply better, IGF-1 LR3 has a relatively narrow therapeutic window
Here are some reasons to consider medical weight loss at Figura: This proven process has changed lives
Ask your healthcare provider what you should expect
Its also important to follow your doctors advice about taking semaglutide and any other medications, as well as maintaining a healthy lifestyle
Additional information Competing interest The authors declare that they have no competing interests
A group of researchers, including oncologists and data scientists, from the University of Florida and Indiana University hypothesized that GLP-1s hold promise in oncology due to their ability to lower glucose, adiposity, insulin resistance, and systemic inflammation factors associated with cancer progression, according to a July 2025 paper published in JAMA